A Cancer Breakthrough That Changes Everything
In a stunning medical advance, Dr. Patrick Soon-Shiong reveals a platform technology achieving near-complete responses in patients with terminal cancers—including brain, pancreatic, and head & neck tumors—after all other treatments failed.
This isn't a traditional chemo or radiation. It's a dual approach that empowers the body's own immune system.
Here’s the revolutionary breakdown:
1. The "BioShield" Injection: The key is a stabilized form of IL-15 (Interleukin-15), a protein that acts as "food" for your Natural Killer (NK) cells. The NIH tried for a decade to develop IL-15 but failed because it naturally lasts only 2 minutes in the body. Dr. Soon-Shiong's team engineered it to last for 7 days with a simple 5-minute subcutaneous injection, continuously proliferating the patient's NK cells.
2. The Combined Infusion: Patients receive this "BioShield" injection along with an infusion of powerful NK cells, creating a targeted army to attack the cancer.
The Proven Results:
- Metastatic Pancreatic Cancer: Patients alive 6 years later.
- Merkel Cell Carcinoma: Patients surviving 9 years.
- Bladder Cancer: Approved by the FDA in April 2024, with patients disease-free for 10 years.
- Lung Cancer: In new trials, the therapy has tripled survival for patients who failed everything, including chemo and checkpoint inhibitors.
The therapy is also being used preemptively. The NCI has designated it for a trial on patients with Lynch syndrome (1 in 280 Americans), who have an 80% higher risk of cancers, to provide a "Cancer BioShield."
The data is based on experience with over 8,000 patients. The challenge now is regulatory. Despite its pan-tumor potential, the current system requires a separate 10-year, 700,000-page approval process for each cancer type.
This is a paradigm shift. We don't ask what kind of anemia you have before a blood transfusion. The body needs NK cells and T-cells to fight cancer, regardless of the tumor type.
For kids on the autism spectrum, flying can be particularly difficult. Learn how we're trying to ease their experience by allowing them to participate in practice flights. https://t.co/naiJMI9UER
"Individuals with disabilities and special needs require advocacy and deserve autonomy."
It takes a personalized, holistic approach to develop the right financial plan for an individual with special needs or a disability. We can help.
Full video: https://t.co/Bsb0GXlwbU
What a beauty! The #777X wing comes together at the #Boeing factory on #wingwednesday. A new wing design, fourth-generation composite and folding wingtips ensure the 777X will be 12% more fuel efficient than the competition. Learn more here: https://t.co/hLTJpwXsGt